Patents by Inventor David Antony Phillip Small

David Antony Phillip Small has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Enzyme inhibitors
    Patent number: 9856230
    Abstract: The present subject matter relates generally to compounds having the formula (I): wherein each of X, Y, R1, R2, R3, R4, and n are as defined herein. Compounds of formula (I) may act as inhibitors of the thioredoxin reductase enzyme system. The subject matter also relates to use, formulation and preparation of the compounds. The compounds may be useful in the treatment of inflammatory and oxidative diseases and conditions. The compounds may also provide useful anti-proliferative and anti-apoptotic effects.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: January 2, 2018
    Assignee: UNIVERSITY OF SUNDERLAND
    Inventors: Adam Todd, Rosaleen Joy Anderson, David Antony Phillip Small, Paul William Groundwater, Matthew Richard Benton
  • Novel compositions and formulations
    Publication number: 20090270438
    Abstract: There is provided according to the invention a non-pressurised pharmaceutical liquid solution spray composition comprising: (i) buprenorphine; and a solvent comprising ethanol which composition is substantially free of chloride. There is also provided according to the invention a non-pressurised pharmaceutical liquid solution spray formulation comprising: (i) buprenorphine; (ii) a solvent comprising ethanol; and (iii) one or more antioxidants each of a molar ratio of antioxidant:buprenorphine between 0.2:1 and 25:1.
    Type: Application
    Filed: April 17, 2009
    Publication date: October 29, 2009
    Inventors: Clive Booles, Padriac O'Brien, David Antony Phillip Small, Matthew John Tyler